MET-2 is the principal H3K9 mono- and dimethyltransferase in C. elegans, homologous to mammalian SETDB1. It catalyzes the sequential addition of one or two methyl groups to lysine 9 of histone H3 using S-adenosyl-L-methionine as the methyl donor, producing H3K9me1 and H3K9me2. MET-2-mediated H3K9 methylation is essential for heterochromatin formation, perinuclear chromatin anchoring, and transcriptional silencing of repetitive elements and developmental genes. The protein functions in a complex with LIN-65 (an ATF7IP homolog that mediates nuclear import and focus formation) and ARLE-14 (which stabilizes chromatin association). MET-2 has both catalytic and noncatalytic roles in gene silencing; even catalytically inactive MET-2 can form foci and maintain some repression by constraining histone acetylation. The enzyme primes chromatin for SET-25-mediated H3K9 trimethylation and is required for multiple developmental processes including vulval cell fate specification, meiotic sex chromosome inactivation, and transgenerational epigenetic inheritance.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0010629
negative regulation of gene expression
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: MET-2 negatively regulates gene expression through H3K9 methylation-mediated heterochromatin formation. Multiple studies demonstrate that MET-2 represses transcription of lin-3 EGF (PMID:17634190), genes on the X chromosome during MSCI (PMID:21909284), and subtype-specific neuronal genes (PMID:24348272). The IBA annotation based on phylogenetic inference is well-supported by experimental evidence.
Reason: This annotation accurately captures a core function of MET-2. As an H3K9 methyltransferase, MET-2 deposits repressive chromatin marks that silence gene expression. This is supported by multiple experimental studies in C. elegans.
Supporting Evidence:
PMID:17634190
met-2 is homologous to human SETDB1, an H3K9 HMT that represses transcription
PMID:24348272
loss of cec-3, met-1, met-2 and lin-13, like loss of pqe-1... suggesting these genes act together to inhibit transcription
|
|
GO:0046974
histone H3K9 methyltransferase activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: MET-2 is established as the principal H3K9 mono- and dimethyltransferase in C. elegans. Towbin et al. (PMID:22939621) demonstrated that "MET-2, a SETDB1 homolog, mediates mono- and dimethylation" of H3K9. This core enzymatic activity is conserved from the SETDB1 family.
Reason: This is the core molecular function of MET-2. The IBA annotation is strongly supported by experimental evidence demonstrating H3K9 methyltransferase activity in vivo.
Supporting Evidence:
PMID:22939621
MET-2, a SETDB1 homolog, mediates mono- and dimethylation
file:worm/met-2/met-2-uniprot.txt
Histone methyltransferase which is required for the mono- and dimethylation of 'Lys-9' of histone H3
|
|
GO:0070828
heterochromatin organization
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: MET-2 is essential for heterochromatin organization in C. elegans. The protein forms nuclear foci that colocalize with H3K9me2 at the nuclear periphery. MET-2-dependent H3K9me2 is required for perinuclear anchoring of heterochromatin domains. Delaney et al. (2019) showed that met-2 mutants abolish peripheral enrichment of autosomal arms.
Reason: Heterochromatin organization is a core biological process for MET-2. The H3K9me2 mark deposited by MET-2 is specifically required for nuclear lamina association and proper heterochromatin architecture.
Supporting Evidence:
PMID:22939621
elimination of two HMTs, MET-2 and SET-25, mimics the loss of SAM synthetase, abrogating the perinuclear attachment of heterochromatic transgenes
file:worm/met-2/met-2-deep-research-falcon.md
met-2 mutants abolish peripheral enrichment of autosomal arms measured by LEM-2 ChIP-seq
|
|
GO:0005634
nucleus
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: MET-2 localizes to the nucleus where it forms subnuclear foci enriched at the nuclear periphery. Nuclear localization is regulated and developmentally timed, with MET-2 accumulating in nuclear hubs at gastrulation (PMID:22939621, Mutlu et al. 2018).
Reason: Nuclear localization is essential for MET-2's chromatin-modifying function. Multiple studies confirm nuclear localization with experimental evidence.
Supporting Evidence:
file:worm/met-2/met-2-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:22939621}
file:worm/met-2/met-2-deep-research-falcon.md
nuclear MET-2 accumulation correlates with linear H3K9me2 increase
|
|
GO:0003677
DNA binding
|
IEA
GO_REF:0000002 |
MARK AS OVER ANNOTATED |
Summary: This annotation is inferred from the MBD (methyl-CpG-binding domain) present in MET-2. However, MET-2's primary substrate is histone H3, not DNA directly. While the MBD domain may contribute to chromatin targeting, there is no direct experimental evidence for sequence-specific DNA binding activity.
Reason: The IEA annotation based on InterPro MBD domain is technically accurate as MET-2 contains an MBD domain (IPR001739), but DNA binding is not the primary or core function. MET-2 functions as a histone methyltransferase and its chromatin targeting involves protein-protein interactions with LIN-65 and ARLE-14 rather than direct DNA binding.
|
|
GO:0005634
nucleus
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: This IEA annotation for nuclear localization is consistent with experimental evidence. MET-2 is a nuclear protein that forms foci at the nuclear periphery.
Reason: Redundant with the IBA annotation but correctly captures nuclear localization, which is experimentally validated.
Supporting Evidence:
file:worm/met-2/met-2-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:22939621}
|
|
GO:0005694
chromosome
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: MET-2 associates with chromatin/chromosomes to deposit H3K9 methylation marks. The UniProt subcellular location indicates chromosome association, which is consistent with its function as a histone-modifying enzyme.
Reason: Chromosome localization is expected for a histone methyltransferase and is supported by functional evidence showing MET-2 modifies chromatin-associated histones.
Supporting Evidence:
file:worm/met-2/met-2-uniprot.txt
SUBCELLULAR LOCATION: Nucleus... Chromosome {ECO:0000305|PubMed:22939621}
|
|
GO:0005737
cytoplasm
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: MET-2 is found in both cytoplasm and nucleus, with regulated nuclear accumulation during development. In early embryos, MET-2 is predominantly cytoplasmic before translocating to the nucleus at gastrulation.
Reason: Cytoplasmic localization is experimentally validated. MET-2's regulated nucleocytoplasmic distribution is an important aspect of its developmental regulation.
Supporting Evidence:
file:worm/met-2/met-2-uniprot.txt
SUBCELLULAR LOCATION: Nucleus... Cytoplasm {ECO:0000269|PubMed:22939621}
file:worm/met-2/met-2-deep-research-falcon.md
MET-2/LIN-65/ARLE-14 move from cytosol to nuclear hubs with development
|
|
GO:0006351
DNA-templated transcription
|
IEA
GO_REF:0000043 |
MODIFY |
Summary: This annotation is too general and does not accurately capture MET-2's role. MET-2 does not directly participate in transcription; rather, it represses transcription through chromatin modification.
Reason: MET-2 is a negative regulator of transcription through heterochromatin formation, not a transcription factor or component of the transcription machinery. The annotation should be more specific about the regulatory role.
Proposed replacements:
negative regulation of gene expression
|
|
GO:0007548
sex differentiation
|
IEA
GO_REF:0000043 |
KEEP AS NON CORE |
Summary: MET-2 plays a role in meiotic sex chromosome inactivation (MSCI) in males. Checchi & Engebrecht (PMID:21909284) showed that MET-2 mediates the transcriptional silencing program of meiotic sex chromosome inactivation. However, this is not a core function of MET-2.
Reason: While MET-2 does function in sex-related processes (MSCI), this represents a context-specific application of its general heterochromatin-forming activity rather than a core function.
Supporting Evidence:
PMID:21909284
MET-2 also mediates the transcriptional silencing program of meiotic sex chromosome inactivation (MSCI)
|
|
GO:0008168
methyltransferase activity
|
IEA
GO_REF:0000043 |
MODIFY |
Summary: MET-2 is indeed a methyltransferase, but this term is too general. The specific activity is histone H3K9 methyltransferase activity (GO:0046974).
Reason: While accurate, this general term should be replaced with the more specific H3K9 methyltransferase activity annotation that better describes MET-2's enzymatic function.
Proposed replacements:
histone H3K9 methyltransferase activity
|
|
GO:0008270
zinc ion binding
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: MET-2's pre-SET domain binds zinc ions in a triangular cluster arrangement. The UniProt entry documents multiple zinc binding sites in the pre-SET and post-SET domains (positions 973, 975, 979, 985, 987, 1030, 1034, 1036, 1041, 1237, 1290, 1292, 1297).
Reason: Zinc binding is structurally important for SET domain-containing methyltransferases and is well-documented for MET-2 based on domain architecture.
Supporting Evidence:
file:worm/met-2/met-2-uniprot.txt
In the pre-SET domain, Cys residues bind 3 zinc ions that are arranged in a triangular cluster
|
|
GO:0016740
transferase activity
|
IEA
GO_REF:0000043 |
MODIFY |
Summary: This is a very general parent term. MET-2 does have transferase activity as it transfers methyl groups, but more specific terms are available.
Reason: Too general. Should be annotated with the specific histone methyltransferase activity terms.
Proposed replacements:
histone H3K9 methyltransferase activity
|
|
GO:0030154
cell differentiation
|
IEA
GO_REF:0000043 |
KEEP AS NON CORE |
Summary: MET-2 does play roles in developmental processes including vulval cell fate specification and neuronal differentiation. However, this is a broad term that encompasses many specific processes.
Reason: While MET-2 does function in cell differentiation contexts (vulval cells, neurons), these are downstream consequences of its core heterochromatin-forming function rather than direct involvement in differentiation machinery.
|
|
GO:0032259
methylation
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: MET-2 catalyzes histone methylation, specifically H3K9 mono- and dimethylation. This general biological process term is accurate but lacks specificity.
Reason: Accurate but general. This term captures the biochemical process but more specific annotations (histone H3K9 methyltransferase activity) better describe the function.
|
|
GO:0042054
histone methyltransferase activity
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: MET-2 is a histone methyltransferase. The annotation is correct but the more specific term GO:0046974 (histone H3K9 methyltransferase activity) should be preferred.
Reason: Accurate annotation based on domain architecture. MET-2 contains SET, pre-SET, and post-SET domains characteristic of histone methyltransferases.
Supporting Evidence:
file:worm/met-2/met-2-uniprot.txt
Histone methyltransferase which is required for the mono- and dimethylation of 'Lys-9' of histone H3
|
|
GO:0046872
metal ion binding
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: MET-2 binds zinc ions through its pre-SET and post-SET domains. This general term is accurate but the more specific zinc ion binding (GO:0008270) is preferred.
Reason: Accurate but general. Zinc binding is documented and functionally relevant for the SET domain architecture.
|
|
GO:0046974
histone H3K9 methyltransferase activity
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: MET-2 catalyzes H3K9 mono- and dimethylation. This is the core molecular function and is well-supported by experimental evidence.
Reason: Core molecular function annotation. Redundant with IBA and IMP annotations but correctly captures the enzymatic activity.
Supporting Evidence:
PMID:22939621
MET-2, a SETDB1 homolog, mediates mono- and dimethylation
|
|
GO:0051321
meiotic cell cycle
|
IEA
GO_REF:0000043 |
KEEP AS NON CORE |
Summary: MET-2 functions in meiosis, particularly in meiotic sex chromosome inactivation and checkpoint regulation. PMID:21909284 shows MET-2 shields the male X chromosome from checkpoint machinery and mediates MSCI.
Reason: While MET-2 does function during meiosis, this represents a specific developmental context for its general heterochromatin function rather than direct involvement in cell cycle progression.
Supporting Evidence:
PMID:21909284
MET-2 shields the male X chromosome from checkpoint machinery and mediates meiotic sex chromosome inactivation
|
|
GO:0140948
histone H3K9 monomethyltransferase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: MET-2 specifically catalyzes H3K9 monomethylation as the first step in sequential H3K9 methylation. This is a core enzymatic activity supported by PMID:22939621.
Reason: This specific molecular function is well-documented. MET-2 catalyzes the first step (H3K9me0 to H3K9me1) of the H3K9 methylation pathway.
Supporting Evidence:
PMID:22939621
MET-2, a SETDB1 homolog, mediates mono- and dimethylation
file:worm/met-2/met-2-uniprot.txt
Histone methyltransferase which is required for the mono- and dimethylation of 'Lys-9' of histone H3
|
|
GO:0005634
nucleus
|
IC
PMID:17634190 Two C. elegans histone methyltransferases repress lin-3 EGF ... |
ACCEPT |
Summary: Nuclear localization inferred by curator from the gene's function in transcriptional repression via histone modification.
Reason: Correct annotation. Nuclear localization is experimentally validated in multiple studies.
Supporting Evidence:
PMID:17634190
met-2 is homologous to human SETDB1, an H3K9 HMT that represses transcription
file:worm/met-2/met-2-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:22939621}
|
|
GO:0046974
histone H3K9 methyltransferase activity
|
IMP
PMID:17634190 Two C. elegans histone methyltransferases repress lin-3 EGF ... |
ACCEPT |
Summary: Andersen & Horvitz demonstrated that met-1 and met-2 mutant embryos had reduced H3K9 trimethylation, indicating MET-2 contributes to H3K9 methylation. While this study focused on trimethylation phenotypes, later work (PMID:22939621) clarified that MET-2 specifically mediates mono- and dimethylation.
Reason: Core molecular function with direct experimental support. The IMP evidence from mutant phenotypes supports H3K9 methyltransferase activity.
Supporting Evidence:
PMID:17634190
met-1 and met-2 (1) are each required for the normal trimethylation of both H3K9 and H3K36
|
|
GO:0046975
histone H3K36 methyltransferase activity
|
IMP
PMID:17634190 Two C. elegans histone methyltransferases repress lin-3 EGF ... |
REMOVE |
Summary: Andersen & Horvitz reported that met-2 mutants showed reduced H3K36 trimethylation. However, this is likely an indirect effect. MET-2 is homologous to SETDB1, which is an H3K9-specific methyltransferase. MET-1 (SET2 homolog) is the direct H3K36 methyltransferase. The observed H3K36me3 reduction in met-2 mutants may reflect crosstalk between these marks or indirect effects on MET-1 activity.
Reason: This annotation is likely incorrect based on evolutionary conservation and biochemical specificity. SETDB1-family proteins are H3K9-specific methyltransferases. The observed H3K36me3 phenotype in met-2 mutants is more likely an indirect consequence of H3K9me loss affecting H3K36 methylation machinery, not direct catalytic activity on H3K36. UniProt catalytic activity annotations (EC 2.1.1.367) specify H3K9 as the substrate.
Supporting Evidence:
PMID:17634190
met-1 and met-2 (1) are each required for the normal trimethylation of both H3K9 and H3K36
|
|
GO:0010629
negative regulation of gene expression
|
IMP
PMID:24348272 Histone methylation restrains the expression of subtype-spec... |
ACCEPT |
Summary: Uchida et al. showed that met-2 mutants derepress unc-4 expression in vulval VC neurons. "Endogenous unc-4 transcripts accumulate in all six VC neurons in pqe-1, cec-3, and met-2 mutants" - demonstrating MET-2's role in silencing subtype-specific gene expression.
Reason: Core biological process with direct experimental evidence. Loss of met-2 leads to ectopic gene expression, demonstrating negative regulation of gene expression.
Supporting Evidence:
PMID:24348272
Endogenous unc-4 transcripts accumulate in all six VC neurons in pqe-1, cec-3, and met-2 mutants
PMID:24348272
MET-2 is the C. elegans homolog of human SETDB1
|
|
GO:0040029
epigenetic regulation of gene expression
|
IMP
PMID:24979765 SPR-5 and MET-2 function cooperatively to reestablish an epi... |
ACCEPT |
Summary: Kerr et al. demonstrated that MET-2 functions in transgenerational epigenetic reprogramming with SPR-5. SPR-5 and MET-2 function cooperatively to reestablish an epigenetic ground state during passage through the germ line. spr-5;met-2 double mutants show transgenerational sterility and heritable epigenetic defects.
Reason: Core biological process demonstrating MET-2's role in epigenetic inheritance and germline reprogramming. This is a key function supported by strong experimental evidence.
Supporting Evidence:
PMID:24979765
SPR-5 and MET-2 function cooperatively to reestablish an epigenetic ground state during passage through the germ line
|
|
GO:0005737
cytoplasm
|
IDA
PMID:22939621 Step-wise methylation of histone H3K9 positions heterochroma... |
ACCEPT |
Summary: Towbin et al. demonstrated cytoplasmic localization of MET-2, particularly in early embryos before nuclear accumulation. The regulated nucleocytoplasmic distribution is an important aspect of developmental timing of heterochromatin formation.
Reason: Direct experimental evidence (IDA) for cytoplasmic localization. MET-2's regulated nuclear import is key to timing heterochromatin establishment.
Supporting Evidence:
PMID:22939621
The two HMTs target H3K9 in a consecutive fashion: MET-2, a SETDB1 homolog, mediates mono- and dimethylation
file:worm/met-2/met-2-uniprot.txt
SUBCELLULAR LOCATION: Nucleus... Cytoplasm {ECO:0000269|PubMed:22939621}
file:worm/met-2/met-2-deep-research-falcon.md
MET-2/LIN-65/ARLE-14 move from cytosol to nuclear hubs with development
|
|
GO:0045835
negative regulation of meiotic nuclear division
|
IMP
PMID:21909284 Caenorhabditis elegans histone methyltransferase MET-2 shiel... |
KEEP AS NON CORE |
Summary: Checchi & Engebrecht showed that MET-2 shields the male X chromosome from checkpoint machinery. Loss of met-2 leads to increased apoptosis through activation of the recombination checkpoint in X0 germ lines. However, MET-2 does not directly regulate meiotic division; rather, it prevents checkpoint-induced cell death.
Reason: This represents a specific context-dependent phenotype rather than a direct role in regulating meiotic nuclear division. MET-2's function here is to silence the X chromosome to prevent inappropriate checkpoint activation, not to directly regulate meiosis.
Supporting Evidence:
PMID:21909284
Absence of met-2 in X0 germ lines results in increased apoptosis by activating the recombination checkpoint
PMID:21909284
Absence of MET-2 triggers the recombination checkpoint in worms with a single X
|
|
GO:0072325
vulval cell fate commitment
|
IMP
PMID:21437264 H3K9me2/3 binding of the MBT domain protein LIN-61 is essent... |
KEEP AS NON CORE |
Summary: Koester-Eiserfunke & Fischle demonstrated that MET-2 functions in vulval cell fate determination through H3K9 methylation. LIN-61 acts with HPL-2 and MET-2 in this pathway. Double mutants between lin-61 and met-2 show enhanced vulval defects.
Reason: Vulval development is a well-studied context for MET-2 function, but this is a tissue-specific manifestation of the general gene silencing function rather than a core function of the protein.
Supporting Evidence:
PMID:21437264
establish interplay of the H3K9me2/3 binding proteins, LIN-61 and HPL-2, as well as the H3K9MT MET-2 in distinct developmental pathways
PMID:17634190
identified met-1 and met-2 as negative regulators of vulval cell-fate specification
|
|
GO:0000122
negative regulation of transcription by RNA polymerase II
|
IGI
PMID:17634190 Two C. elegans histone methyltransferases repress lin-3 EGF ... |
ACCEPT |
Summary: Andersen & Horvitz showed that MET-2 represses lin-3 EGF transcription. Genetic interactions demonstrate that met-1 and met-2 act redundantly with HP1 homologs to repress transcription.
Reason: Direct evidence for transcriptional repression function. This is more specific than the general "negative regulation of gene expression" and captures the mechanism of action.
Supporting Evidence:
PMID:17634190
repress transcription of the EGF gene lin-3, which encodes the signal that induces vulval development
|
|
GO:0040027
negative regulation of vulval development
|
IGI
PMID:17634190 Two C. elegans histone methyltransferases repress lin-3 EGF ... |
KEEP AS NON CORE |
Summary: MET-2 negatively regulates vulval development by repressing lin-3 EGF expression. Genetic interactions with HP1 homologs and NuRD complex components support this role.
Reason: While experimentally validated with strong genetic evidence, vulval development regulation is a tissue-specific phenotype resulting from MET-2's general function in transcriptional repression rather than a core function.
Supporting Evidence:
PMID:17634190
identified met-1 and met-2 as negative regulators of vulval cell-fate specification
PMID:17634190
repress transcription of the EGF gene lin-3, which encodes the signal that induces vulval development
|
|
GO:0140942
histone H3K9 dimethyltransferase activity
|
IMP
PMID:22939621 Step-wise methylation of histone H3K9 positions heterochroma... |
NEW |
Summary: MET-2 catalyzes the conversion of H3K9me1 to H3K9me2. Towbin et al. demonstrated that "MET-2, a SETDB1 homolog, mediates mono- and dimethylation" of H3K9.
Reason: This specific enzymatic activity is a core molecular function of MET-2 and should be annotated. H3K9 dimethyltransferase activity (GO:0140942) specifically captures the me1-to-me2 conversion that MET-2 catalyzes.
Supporting Evidence:
PMID:22939621
MET-2, a SETDB1 homolog, mediates mono- and dimethylation
file:worm/met-2/met-2-deep-research-falcon.md
approximately 10-fold H3K9me2 increase between 20-50 and 51-100 cell stages
|
|
GO:0140719
constitutive heterochromatin formation
|
IMP
PMID:22939621 Step-wise methylation of histone H3K9 positions heterochroma... |
NEW |
Summary: MET-2 is essential for constitutive heterochromatin formation through H3K9me2 deposition. This mark is characteristic of constitutive heterochromatin in metazoa.
Reason: Constitutive heterochromatin formation is more specific than "heterochromatin organization" and better captures MET-2's role in establishing stable, refractory chromatin domains at repeats and the nuclear periphery.
Supporting Evidence:
PMID:22939621
elimination of two HMTs, MET-2 and SET-25, mimics the loss of SAM synthetase, abrogating the perinuclear attachment of heterochromatic transgenes
file:worm/met-2/met-2-deep-research-falcon.md
MET-2/H3K9me2 is essential for perinuclear anchoring of autosomal arms
|
|
GO:0010526
transposable element silencing
|
IMP
PMID:27668659 Histone H3K9 methylation is dispensable for Caenorhabditis e... |
NEW |
Summary: MET-2 and SET-25 together protect repeat-rich genomic regions including transposable elements by suppressing transcription-induced replication stress through H3K9 methylation.
Reason: Transposon silencing is a key function of H3K9 methyltransferases and represents a core biological process for MET-2. The UniProt function annotation specifically mentions this role.
Supporting Evidence:
PMID:27668659
H3K9me2 or H3K9me3 stabilizes and protects repeat-rich genomes by suppressing transcription-induced replication stress
file:worm/met-2/met-2-deep-research-falcon.md
loss destabilizes nuclear MET-2, lowers H3K9me2, disperses foci, and derepresses repeats
|
Q: Is MET-2 H3K9me1 activity truly sequential (me0->me1 then me1->me2) or can it add two methyl groups processively?
Q: What targets MET-2 to specific genomic loci - is it small RNA-dependent targeting via NRDE-3?
Q: Does MET-2 have any non-histone substrates?
Q: What is the molecular basis for the noncatalytic silencing function of MET-2?
Experiment: In vitro methyltransferase assay with recombinant MET-2 to confirm H3K9me1 and H3K9me2 product formation
Experiment: ChIP-seq for MET-2 compared to H3K9me2 to identify direct genomic targets
Experiment: Structural studies of MET-2-LIN-65-ARLE-14 complex
Experiment: Identify MET-2 interacting proteins by IP-MS in embryos at different developmental stages
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2025-12-28T10:56:44.649334'
end_time: '2025-12-28T11:01:08.558436'
duration_seconds: 263.91
template_file: templates/gene_research_go_focused.md
template_variables:
organism: worm
gene_id: met-2
gene_symbol: met-2
uniprot_accession: P34544
protein_description: 'RecName: Full=Histone-lysine N-methyltransferase met-2; EC=2.1.1.-
{ECO:0000305|PubMed:22939621}; EC=2.1.1.367 {ECO:0000305|PubMed:22939621};'
gene_info: Name=met-2; ORFNames=R05D3.11;
organism_full: Caenorhabditis elegans.
protein_family: Belongs to the class V-like SAM-binding methyltransferase
protein_domains: DNA-bd_dom_sf. (IPR016177); Methyl_CpG_DNA-bd. (IPR001739); Post-SET_dom.
(IPR003616); Pre-SET_dom. (IPR007728); SET_dom. (IPR001214)
provider_config:
timeout: 600
max_retries: 3
parameters:
allowed_domains: []
temperature: 0.1
citation_count: 20
BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.
DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'met-2' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information
Please provide a comprehensive research report on the gene met-2 (gene ID: met-2, UniProt: P34544) in worm.
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Question: You are an expert researcher providing comprehensive, well-cited information.
Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies
Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.
BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.
DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'met-2' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information
Please provide a comprehensive research report on the gene met-2 (gene ID: met-2, UniProt: P34544) in worm.
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Plan and verification
- Identity check: We confirm the target is C. elegans met-2 (UniProt P34544), encoding a SET domain class V-like SAM-dependent histone-lysine N-methyltransferase homologous to vertebrate SETDB1/SETDB2. Literature consistently assigns MET-2 as the principal H3K9 mono- and di-methyltransferase in C. elegans embryos; SET-25 catalyzes H3K9 trimethylation. Key cofactors LIN-65 (ATF7IP-like) and ARLE-14 (ARL14EP-like) modulate MET-2 localization and chromatin association. These features align with the UniProt family and domain annotations (Pre-SET/SET/Post-SET) and with conserved SETDB biology. We find no conflicting use of the symbol “met-2” that would suggest a different gene in C. elegans. (mutlu2018regulatednuclearaccumulation pages 1-2, padeken2022establishmentofh3k9methylated pages 2-3, jash2024chromatinorganizationduring pages 2-4, delaney2019heterochromaticfociand pages 8-10)
Comprehensive research report
1) Key concepts and definitions with current understanding
- Enzymatic identity and reaction: MET-2 is the C. elegans SETDB1-like histone methyltransferase that deposits H3K9me1 and H3K9me2 in vivo, using S-adenosyl-L-methionine as methyl donor. SET-25 performs most H3K9me3 deposition. This division of labor is supported by genetic and biochemical evidence in worms and is consistent with conserved SETDB1 functions in other animals. (jash2024chromatinorganizationduring pages 2-4, padeken2022establishmentofh3k9methylated pages 2-3)
• Jash & Csankovszki (2024, review; DNA 4(1):64–83; published Feb 2024) summarize that MET-2 deposits H3K9me1/2 and SET-25 deposits H3K9me3 in C. elegans embryos; they compile multiple primary studies supporting this model. URL: https://doi.org/10.3390/dna4010004 (jash2024chromatinorganizationduring pages 2-4)
• Padeken, Methot & Gasser (2022, review; Nat Rev Mol Cell Biol 23:623–640; May 2022) discuss conserved H3K9 HMT modules and note worm MET-2’s SETDB-like features and partners; SET-25 catalyzes H3K9me3 including de novo nucleation via small-RNA pathways. URL: https://doi.org/10.1038/s41580-022-00483-w (padeken2022establishmentofh3k9methylated pages 2-3)
- Substrate specificity: In embryos, H3K9me2 rises sharply at gastrulation with MET-2 nuclear accumulation; H3K9me1 rises modestly; H3K9me3 also increases but is largely SET-25–dependent downstream of MET-2 priming. Quantitation by Mutlu et al. shows ~10-fold H3K9me2 increase between ~20–50 and 51–100 cell stages, ~2-fold H3K9me1, and ~6-fold H3K9me3, linking MET-2 activity to heterochromatin onset. URL: https://doi.org/10.1126/sciadv.aat6224 (Aug 2018) (mutlu2018regulatednuclearaccumulation pages 1-2)
- Biological role: H3K9 methylation marks heterochromatin at repeats/transposons and lineage-restricted genes, promoting transcriptional silencing, nuclear lamina association, and normal development. MET-2-dependent H3K9me2 is crucial for perinuclear anchoring; SET-25-mediated H3K9me3 is not strictly required for lamina tethering. URL: https://doi.org/10.1083/jcb.201811038 (Mar 2019) (delaney2019heterochromaticfociand pages 8-10)
2) Recent developments and latest research (emphasis 2023–2024)
- Developmental timing via XOL-1→MET-2 axis (2024): Jash et al. (PLOS Genetics; Aug 15, 2024) show that the sex-determination factor XOL-1, although low in hermaphrodites, regulates embryonic developmental timing and dosage compensation by modulating MET-2. Loss of xol-1 causes increased MET-2 expression and altered H3K9me2/3 in 20–100 cell embryos; met-2;xol-1 double mutants partially or fully reverse several accelerated-development phenotypes and precocious DCC loading. URL: https://doi.org/10.1371/journal.pgen.1011238 (jash2024xol1regulatesdevelopmental pages 3-5, jash2024xol1regulatesdevelopmental pages 15-17)
• Quantitative highlights: H3K9me2/H3 levels significantly increase in xol-1 embryos at 20–50 cell (p=2.9×10−6) and 50–100 cell (p=4.2×10−14); H3K9me3 also increases (p=6.1×10−7 at 50–100 cells), and timing phenotypes (8-cell→bean, bean→2-fold transitions) are delayed toward WT when met-2 is removed in the xol-1 background. (jash2024xol1regulatesdevelopmental pages 15-17)
- H3K9me readers in lifespan/aging (2023): Hou et al. (Nature Communications; Mar 2023) systematically map chromodomain proteins and identify CEC-5 as an H3K9me1/2 reader whose chromatin association requires MET-2 and H3K9me1/2 at a substantial fraction of sites; both MET-2 and CEC-5 are required for normal lifespan. URL: https://doi.org/10.1038/s41467-023-36898-y (hou2023systematiccharacterizationof pages 8-11)
• Imaging/ChIP data show that met-2 mutation disrupts CEC-5 puncta and reduces CEC-5 binding at 779/3558 peaks enriched for H3K9me2; set-25 loss alone has minimal impact on these CEC-5 sites. (hou2023systematiccharacterizationof pages 8-11)
- Updated perspectives on embryonic chromatin organization (2024): Jash & Csankovszki review (Feb 2024) integrate MET-2’s nuclear hub formation with lamina tethering and the timing of heterochromatin onset; they emphasize LIN-65–mediated nuclear import and ARLE-14–mediated chromatin association, and note temperature/S-phase influences on MET-2 nuclear accumulation. URL: https://doi.org/10.3390/dna4010004 (jash2024chromatinorganizationduring pages 2-4)
3) Current applications and real-world implementations
- Temporal control of heterochromatin via MET-2 nuclear targeting: Mutlu et al. (2018) demonstrate that enforced nuclear accumulation of MET-2 leads to precocious H3K9 methylation and early heterochromatin domain formation, identifying a lever to time epigenome transitions during embryogenesis. URL: https://doi.org/10.1126/sciadv.aat6224 (mutlu2018regulatednuclearaccumulation pages 8-9, mutlu2018regulatednuclearaccumulation pages 1-2)
• Quantitative kinetics: nuclear MET-2 accumulation correlates with linear H3K9me2 increase; wild-type slopes vs arle-14 mutants show attenuated accumulation (e.g., 1–20 to 51–100 cells: slope ~0.41 WT vs ~0.15 arle-14), indicating ARLE-14’s role in chromatin engagement kinetics. (mutlu2018regulatednuclearaccumulation pages 8-9)
- Nuclear lamina/heterochromatin anchoring readouts: Delaney et al. (2019) use LEM-2 ChIP-seq, FISH, and reporters to show that met-2 loss abolishes peripheral association of autosomal arms whereas set-25 loss largely retains arm-periphery enrichment—implicating MET-2/H3K9me2 in perinuclear organization used as a cellular readout for heterochromatin integrity under stress or genetic perturbation. URL: https://doi.org/10.1083/jcb.201811038 (delaney2019heterochromaticfociand pages 8-10)
- Noncatalytic MET-2 function as a tool: Delaney et al. (2022) engineered a catalytically deficient MET-2 allele (C1237A; met-2-CD) that still forms LIN-65–dependent foci and partially maintains gene silencing and developmental fitness; this tool separates catalytic from structural roles for mechanistic dissection. URL: https://doi.org/10.1038/s41594-021-00712-4 (Jan 2022) (delaney2022setdb1likemet2promotes pages 4-5)
- Lifespan and chromodomain reporters: Hou et al. (2023) CRISPR-tagged chromodomain factors including CEC-5, enabling in vivo readouts of heterochromatin states sensitive to MET-2 and SUMOylation; platform applicable to aging and stress studies. URL: https://doi.org/10.1038/s41467-023-36898-y (hou2023systematiccharacterizationof pages 8-11)
4) Expert opinions and analysis from authoritative sources
- Conserved SETDB modules and reader/writer logic: Padeken et al. (2022) emphasize that MET-2 (worm SETDB1-like) associates with ATF7IP-like LIN-65 and ARLE-14, paralleling vertebrate SETDB1 with ATF7IP/KAP1/HP1. They highlight H3K9me1 as a priming state for SUV39-family H3K9me2/3 and the role of readers (HP1-like HPL-2; CEC-4/CEC-5) in chromatin compaction and nuclear architecture. URL: https://doi.org/10.1038/s41580-022-00483-w (padeken2022establishmentofh3k9methylated pages 2-3)
- Developmental timing of heterochromatin: Mutlu et al. (2018) provide a widely cited mechanistic framework: MET-2’s regulated nuclear accumulation establishes the onset of heterochromatin domains, with LIN-65 rate-limiting for nuclear entry and ARLE-14 stabilizing chromatin association. URL: https://doi.org/10.1126/sciadv.aat6224 (mutlu2018regulatednuclearaccumulation pages 1-2, mutlu2018regulatednuclearaccumulation pages 8-9)
- Nuclear lamina tethering: Delaney et al. (2019) argue MET-2/H3K9me2 is essential for perinuclear anchoring of autosomal arms, whereas H3K9me3 is dispensable for this specific architectural feature—refining the functional map of H3K9 states. URL: https://doi.org/10.1083/jcb.201811038 (delaney2019heterochromaticfociand pages 8-10)
- 2024 synthesis: Jash & Csankovszki (2024) incorporate new developmental regulators (e.g., XOL-1) and physiological variables (temperature, S-phase) into the MET-2 timing model, underscoring system-level control. URL: https://doi.org/10.3390/dna4010004 (jash2024chromatinorganizationduring pages 2-4)
5) Relevant statistics and data from recent and foundational studies
- H3K9 dynamics at gastrulation (Mutlu 2018, Sci Adv): ~10× increase in H3K9me2 (with MET-2 hubs), ~2× H3K9me1, ~6× H3K9me3 between ~20–50 and 51–100 cell stages; MET-2/LIN-65/ARLE-14 move from cytosol to nuclear hubs with development. URL: https://doi.org/10.1126/sciadv.aat6224 (mutlu2018regulatednuclearaccumulation pages 1-2)
- ARLE-14 effect sizes (Mutlu 2018): Early accumulation slopes of H3K9me2 are reduced in arle-14 mutants (e.g., 1–20→5–20 cells: ~0.11 WT vs ~0.02 arle-14; later 51–100 cells: ~0.41 WT vs ~0.15 arle-14), quantifying its role in MET-2 chromatin association. URL: https://doi.org/10.1126/sciadv.aat6224 (mutlu2018regulatednuclearaccumulation pages 8-9)
- Perinuclear tethering dependency (Delaney 2019, JCB): met-2 mutants abolish peripheral enrichment of autosomal arms measured by LEM-2 ChIP-seq and FISH; set-25 mutants retain arm-periphery enrichment, indicating H3K9me2 (not me3) is crucial for lamina association. URL: https://doi.org/10.1083/jcb.201811038 (delaney2019heterochromaticfociand pages 8-10)
- Noncatalytic MET-2 function (Delaney 2022, NSMB): met-2-CD reduces H3K9me2/3 to met-2Δ levels yet forms normal foci; met-2-CD animals show higher fertility than met-2Δ and maintain silencing at select loci by preventing H3K9/H3K27 acetylation increase. URLs: https://doi.org/10.1038/s41594-021-00712-4 (delaney2022setdb1likemet2promotes pages 4-5)
- XOL-1→MET-2 developmental timing (Jash 2024, PLOS Genet): xol-1 null elevates H3K9me2/3 in staged embryos (p-values: 2.9×10−6, 4.2×10−14 for H3K9me2; 6.1×10−7 for H3K9me3) and accelerates development; met-2 loss in xol-1 reverses accelerated transitions (8-cell→bean, bean→2-fold) and reduces precocious DCC loading categories. URL: https://doi.org/10.1371/journal.pgen.1011238 (jash2024xol1regulatesdevelopmental pages 3-5, jash2024xol1regulatesdevelopmental pages 15-17)
- H3K9me reader dependence and lifespan (Hou 2023, Nat Commun): CEC-5 puncta require MET-2; 779/3558 CEC-5 ChIP peaks reduced in met-2;set-25 double mutants and met-2 single mutants, but not set-25 alone; MET-2 and CEC-5 are both required for normal lifespan. URL: https://doi.org/10.1038/s41467-023-36898-y (hou2023systematiccharacterizationof pages 8-11)
Mechanistic synthesis: function, localization, partners, pathways
- Catalysis and pathway placement: MET-2 lays down H3K9me1/2 that primes and scaffolds heterochromatin formation, including recruitment/propagation of H3K9me3 by SET-25 at select loci (some via NRDE-3-dependent small RNA pathways). MET-2’s H3K9me2, more than H3K9me3, underpins lamina-associated domain (LAD) tethering in embryos. (jash2024chromatinorganizationduring pages 2-4, padeken2022establishmentofh3k9methylated pages 2-3, delaney2019heterochromaticfociand pages 8-10)
- Localization: Endogenous MET-2 is nuclear throughout development but concentrates into subnuclear hubs/foci at gastrulation; these foci are enriched at the periphery and co-localize with H3K9me2, while excluding active marks. Foci display stress-responsive dynamics (heat shock dispersal and recovery) paralleling LIN-65 behavior. (delaney2019heterochromaticfociand pages 8-10, mutlu2018regulatednuclearaccumulation pages 1-2)
- Cofactors: LIN-65 is ATF7IP-like, largely unstructured, and rate-limits MET-2 nuclear accumulation and focus formation; its loss destabilizes nuclear MET-2, lowers H3K9me2, disperses foci, and derepresses repeats and MET-2 targets. ARLE-14 enhances MET-2’s stable chromatin association and the kinetics of H3K9me2 accumulation; arle-14 mutants show delayed H3K9me2 accumulation with reduced slopes. (mutlu2018regulatednuclearaccumulation pages 8-9, mutlu2018regulatednuclearaccumulation pages 1-2, delaney2019heterochromaticfociand pages 8-10)
- Noncatalytic role: MET-2—via LIN-65–dependent foci—can repress specific genes and maintain fertility/fitness independently of H3K9 methyltransferase activity, in part by constraining histone acetylation (H3K9ac/H3K27ac). This separates structural/organizational functions from catalytic ones. (delaney2022setdb1likemet2promotes pages 4-5)
- Readers and aging: CEC-5 reads H3K9me1/2 in vitro and in vivo, requiring MET-2 for proper chromatin association and nuclear puncta; MET-2 and CEC-5 jointly support normal lifespan in C. elegans, linking MET-2’s marks to aging biology. (hou2023systematiccharacterizationof pages 8-11)
- Dosage compensation/sex determination: XOL-1 modulates MET-2 expression and thereby the H3K9 landscape and developmental timing in hermaphrodite embryos; MET-2 loss suppresses accelerated developmental phenotypes and precocious DCC loading in xol-1 mutants. (jash2024xol1regulatesdevelopmental pages 3-5, jash2024xol1regulatesdevelopmental pages 15-17)
Limitations and open questions
- How MET-2 is targeted to specific sequences (e.g., repeats vs developmental genes) remains an active area, likely involving small RNAs (NRDE-3) and readers like CEC proteins. The exact biochemical determinants of LIN-65/ARLE-14 interactions and whether MET-2–LIN-65 hubs are phase-separated condensates warrant further biophysical work. (jash2024chromatinorganizationduring pages 2-4, padeken2022establishmentofh3k9methylated pages 2-3, delaney2019heterochromaticfociand pages 8-10)
References with URLs and dates (selection)
- Mutlu et al., Science Advances, Aug 2018. Regulated nuclear accumulation of a histone methyltransferase times the onset of heterochromatin formation in C. elegans embryos. URL: https://doi.org/10.1126/sciadv.aat6224 (mutlu2018regulatednuclearaccumulation pages 8-9, mutlu2018regulatednuclearaccumulation pages 1-2, mutlu2018regulatednuclearaccumulation pages 14-14)
- Delaney et al., Journal of Cell Biology, Mar 2019. Heterochromatic foci and transcriptional repression by an unstructured MET-2/SETDB1 co-factor LIN-65. URL: https://doi.org/10.1083/jcb.201811038 (delaney2019heterochromaticfociand pages 8-10)
- Delaney et al., Nature Structural & Molecular Biology, Jan 2022. SETDB1-like MET-2 promotes transcriptional silencing and development independently of its H3K9me-associated catalytic activity. URL: https://doi.org/10.1038/s41594-021-00712-4 (delaney2022setdb1likemet2promotes pages 4-5)
- Padeken, Methot & Gasser, Nature Reviews Mol Cell Biol, May 2022. Establishment of H3K9-methylated heterochromatin… URL: https://doi.org/10.1038/s41580-022-00483-w (padeken2022establishmentofh3k9methylated pages 2-3)
- Hou et al., Nature Communications, Mar 2023. Systematic characterization of chromodomain proteins reveals an H3K9me1/2 reader regulating aging in C. elegans. URL: https://doi.org/10.1038/s41467-023-36898-y (hou2023systematiccharacterizationof pages 8-11)
- Jash & Csankovszki, DNA, Feb 2024. Chromatin Organization during C. elegans Early Development. URL: https://doi.org/10.3390/dna4010004 (jash2024chromatinorganizationduring pages 2-4)
- Jash et al., PLOS Genetics, Aug 15, 2024. XOL-1 regulates developmental timing by modulating the H3K9 landscape in C. elegans early embryos. URL: https://doi.org/10.1371/journal.pgen.1011238 (jash2024xol1regulatesdevelopmental pages 3-5, jash2024xol1regulatesdevelopmental pages 15-17)
Conclusions
MET-2 (UniProt P34544) is the principal H3K9me1/2 writer in C. elegans that times heterochromatin establishment through regulated nuclear accumulation and formation of LIN-65/ARLE-14–dependent nuclear hubs. Its catalytic output (H3K9me2) is essential for lamina tethering and repression of repeats, while a distinct, LIN-65–dependent noncatalytic function helps maintain gene silencing and developmental fitness. In 2023–2024, work linked MET-2’s H3K9 landscape to developmental timing via XOL-1 and to lifespan via the H3K9me1/2 reader CEC-5, highlighting MET-2 as a central hub integrating gene regulation, nuclear architecture, development, and aging. (mutlu2018regulatednuclearaccumulation pages 1-2, delaney2019heterochromaticfociand pages 8-10, delaney2022setdb1likemet2promotes pages 4-5, hou2023systematiccharacterizationof pages 8-11, jash2024chromatinorganizationduring pages 2-4, jash2024xol1regulatesdevelopmental pages 3-5)
References
(mutlu2018regulatednuclearaccumulation pages 1-2): Beste Mutlu, Huei-Mei Chen, James J. Moresco, Barbara D. Orelo, Bing Yang, John M. Gaspar, Sabine Keppler-Ross, John R. Yates, David H. Hall, Eleanor M. Maine, and Susan E. Mango. Regulated nuclear accumulation of a histone methyltransferase times the onset of heterochromatin formation in c. elegans embryos. Science Advances, Aug 2018. URL: https://doi.org/10.1126/sciadv.aat6224, doi:10.1126/sciadv.aat6224. This article has 77 citations and is from a highest quality peer-reviewed journal.
(padeken2022establishmentofh3k9methylated pages 2-3): Jan Padeken, Stephen P. Methot, and Susan M. Gasser. Establishment of h3k9-methylated heterochromatin and its functions in tissue differentiation and maintenance. Nature Reviews. Molecular Cell Biology, 23:623-640, May 2022. URL: https://doi.org/10.1038/s41580-022-00483-w, doi:10.1038/s41580-022-00483-w. This article has 500 citations.
(jash2024chromatinorganizationduring pages 2-4): Eshna Jash and Györgyi Csankovszki. Chromatin organization during c. elegans early development. DNA, 4 1:64-83, Feb 2024. URL: https://doi.org/10.3390/dna4010004, doi:10.3390/dna4010004. This article has 7 citations.
(delaney2019heterochromaticfociand pages 8-10): Colin E. Delaney, Stephen P. Methot, Micol Guidi, Iskra Katic, Susan M. Gasser, and Jan Padeken. Heterochromatic foci and transcriptional repression by an unstructured met-2/setdb1 co-factor lin-65. The Journal of Cell Biology, 218:820-838, Mar 2019. URL: https://doi.org/10.1083/jcb.201811038, doi:10.1083/jcb.201811038. This article has 36 citations.
(jash2024xol1regulatesdevelopmental pages 3-5): Eshna Jash, Anati Alyaa Azhar, Hector Mendoza, Zoey M. Tan, Halle Nicole Escher, Dalia S. Kaufman, and Györgyi Csankovszki. Xol-1 regulates developmental timing by modulating the h3k9 landscape in c. elegans early embryos. PLOS Genetics, 20:e1011238, Aug 2024. URL: https://doi.org/10.1371/journal.pgen.1011238, doi:10.1371/journal.pgen.1011238. This article has 3 citations and is from a domain leading peer-reviewed journal.
(jash2024xol1regulatesdevelopmental pages 15-17): Eshna Jash, Anati Alyaa Azhar, Hector Mendoza, Zoey M. Tan, Halle Nicole Escher, Dalia S. Kaufman, and Györgyi Csankovszki. Xol-1 regulates developmental timing by modulating the h3k9 landscape in c. elegans early embryos. PLOS Genetics, 20:e1011238, Aug 2024. URL: https://doi.org/10.1371/journal.pgen.1011238, doi:10.1371/journal.pgen.1011238. This article has 3 citations and is from a domain leading peer-reviewed journal.
(hou2023systematiccharacterizationof pages 8-11): Xinhao Hou, Mingjing Xu, Chengming Zhu, Jianing Gao, Meili Li, Xiangyang Chen, Cheng Sun, Björn Nashan, Jianye Zang, Ying Zhou, Shouhong Guang, and Xuezhu Feng. Systematic characterization of chromodomain proteins reveals an h3k9me1/2 reader regulating aging in c. elegans. Nature Communications, Mar 2023. URL: https://doi.org/10.1038/s41467-023-36898-y, doi:10.1038/s41467-023-36898-y. This article has 13 citations and is from a highest quality peer-reviewed journal.
(mutlu2018regulatednuclearaccumulation pages 8-9): Beste Mutlu, Huei-Mei Chen, James J. Moresco, Barbara D. Orelo, Bing Yang, John M. Gaspar, Sabine Keppler-Ross, John R. Yates, David H. Hall, Eleanor M. Maine, and Susan E. Mango. Regulated nuclear accumulation of a histone methyltransferase times the onset of heterochromatin formation in c. elegans embryos. Science Advances, Aug 2018. URL: https://doi.org/10.1126/sciadv.aat6224, doi:10.1126/sciadv.aat6224. This article has 77 citations and is from a highest quality peer-reviewed journal.
(delaney2022setdb1likemet2promotes pages 4-5): Colin E. Delaney, Stephen P. Methot, Veronique Kalck, Jan Seebacher, Daniel Hess, Susan M. Gasser, and Jan Padeken. Setdb1-like met-2 promotes transcriptional silencing and development independently of its h3k9me-associated catalytic activity. Nature Structural & Molecular Biology, 29:85-96, Jan 2022. URL: https://doi.org/10.1038/s41594-021-00712-4, doi:10.1038/s41594-021-00712-4. This article has 26 citations and is from a highest quality peer-reviewed journal.
(mutlu2018regulatednuclearaccumulation pages 14-14): Beste Mutlu, Huei-Mei Chen, James J. Moresco, Barbara D. Orelo, Bing Yang, John M. Gaspar, Sabine Keppler-Ross, John R. Yates, David H. Hall, Eleanor M. Maine, and Susan E. Mango. Regulated nuclear accumulation of a histone methyltransferase times the onset of heterochromatin formation in c. elegans embryos. Science Advances, Aug 2018. URL: https://doi.org/10.1126/sciadv.aat6224, doi:10.1126/sciadv.aat6224. This article has 77 citations and is from a highest quality peer-reviewed journal.
id: P34544
gene_symbol: met-2
product_type: PROTEIN
status: COMPLETE
taxon:
id: NCBITaxon:6239
label: Caenorhabditis elegans
description: MET-2 is the principal H3K9 mono- and dimethyltransferase in C. elegans,
homologous to mammalian SETDB1. It catalyzes the sequential addition of one or two
methyl groups to lysine 9 of histone H3 using S-adenosyl-L-methionine as the methyl
donor, producing H3K9me1 and H3K9me2. MET-2-mediated H3K9 methylation is essential
for heterochromatin formation, perinuclear chromatin anchoring, and transcriptional
silencing of repetitive elements and developmental genes. The protein functions
in a complex with LIN-65 (an ATF7IP homolog that mediates nuclear import and focus
formation) and ARLE-14 (which stabilizes chromatin association). MET-2 has both
catalytic and noncatalytic roles in gene silencing; even catalytically inactive
MET-2 can form foci and maintain some repression by constraining histone acetylation.
The enzyme primes chromatin for SET-25-mediated H3K9 trimethylation and is required
for multiple developmental processes including vulval cell fate specification, meiotic
sex chromosome inactivation, and transgenerational epigenetic inheritance.
existing_annotations:
- term:
id: GO:0010629
label: negative regulation of gene expression
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: MET-2 negatively regulates gene expression through H3K9 methylation-mediated
heterochromatin formation. Multiple studies demonstrate that MET-2 represses
transcription of lin-3 EGF (PMID:17634190), genes on the X chromosome during
MSCI (PMID:21909284), and subtype-specific neuronal genes (PMID:24348272). The
IBA annotation based on phylogenetic inference is well-supported by experimental
evidence.
action: ACCEPT
reason: This annotation accurately captures a core function of MET-2. As an H3K9
methyltransferase, MET-2 deposits repressive chromatin marks that silence gene
expression. This is supported by multiple experimental studies in C. elegans.
supported_by:
- reference_id: PMID:17634190
supporting_text: met-2 is homologous to human SETDB1, an H3K9 HMT that represses
transcription
- reference_id: PMID:24348272
supporting_text: loss of cec-3, met-1, met-2 and lin-13, like loss of pqe-1...
suggesting these genes act together to inhibit transcription
- term:
id: GO:0046974
label: histone H3K9 methyltransferase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: MET-2 is established as the principal H3K9 mono- and dimethyltransferase
in C. elegans. Towbin et al. (PMID:22939621) demonstrated that "MET-2, a SETDB1
homolog, mediates mono- and dimethylation" of H3K9. This core enzymatic activity
is conserved from the SETDB1 family.
action: ACCEPT
reason: This is the core molecular function of MET-2. The IBA annotation is strongly
supported by experimental evidence demonstrating H3K9 methyltransferase activity
in vivo.
supported_by:
- reference_id: PMID:22939621
supporting_text: MET-2, a SETDB1 homolog, mediates mono- and dimethylation
- reference_id: file:worm/met-2/met-2-uniprot.txt
supporting_text: Histone methyltransferase which is required for the mono- and
dimethylation of 'Lys-9' of histone H3
- term:
id: GO:0070828
label: heterochromatin organization
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: MET-2 is essential for heterochromatin organization in C. elegans. The
protein forms nuclear foci that colocalize with H3K9me2 at the nuclear periphery.
MET-2-dependent H3K9me2 is required for perinuclear anchoring of heterochromatin
domains. Delaney et al. (2019) showed that met-2 mutants abolish peripheral
enrichment of autosomal arms.
action: ACCEPT
reason: Heterochromatin organization is a core biological process for MET-2. The
H3K9me2 mark deposited by MET-2 is specifically required for nuclear lamina
association and proper heterochromatin architecture.
supported_by:
- reference_id: PMID:22939621
supporting_text: elimination of two HMTs, MET-2 and SET-25, mimics the loss
of SAM synthetase, abrogating the perinuclear attachment of heterochromatic
transgenes
- reference_id: file:worm/met-2/met-2-deep-research-falcon.md
supporting_text: met-2 mutants abolish peripheral enrichment of autosomal arms
measured by LEM-2 ChIP-seq
- term:
id: GO:0005634
label: nucleus
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: MET-2 localizes to the nucleus where it forms subnuclear foci enriched
at the nuclear periphery. Nuclear localization is regulated and developmentally
timed, with MET-2 accumulating in nuclear hubs at gastrulation (PMID:22939621,
Mutlu et al. 2018).
action: ACCEPT
reason: Nuclear localization is essential for MET-2's chromatin-modifying function.
Multiple studies confirm nuclear localization with experimental evidence.
supported_by:
- reference_id: file:worm/met-2/met-2-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:22939621}'
- reference_id: file:worm/met-2/met-2-deep-research-falcon.md
supporting_text: nuclear MET-2 accumulation correlates with linear H3K9me2 increase
- term:
id: GO:0003677
label: DNA binding
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: This annotation is inferred from the MBD (methyl-CpG-binding domain)
present in MET-2. However, MET-2's primary substrate is histone H3, not DNA
directly. While the MBD domain may contribute to chromatin targeting, there
is no direct experimental evidence for sequence-specific DNA binding activity.
action: MARK_AS_OVER_ANNOTATED
reason: The IEA annotation based on InterPro MBD domain is technically accurate
as MET-2 contains an MBD domain (IPR001739), but DNA binding is not the primary
or core function. MET-2 functions as a histone methyltransferase and its chromatin
targeting involves protein-protein interactions with LIN-65 and ARLE-14 rather
than direct DNA binding.
- term:
id: GO:0005634
label: nucleus
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: This IEA annotation for nuclear localization is consistent with experimental
evidence. MET-2 is a nuclear protein that forms foci at the nuclear periphery.
action: ACCEPT
reason: Redundant with the IBA annotation but correctly captures nuclear localization,
which is experimentally validated.
supported_by:
- reference_id: file:worm/met-2/met-2-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:22939621}'
- term:
id: GO:0005694
label: chromosome
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: MET-2 associates with chromatin/chromosomes to deposit H3K9 methylation
marks. The UniProt subcellular location indicates chromosome association, which
is consistent with its function as a histone-modifying enzyme.
action: ACCEPT
reason: Chromosome localization is expected for a histone methyltransferase and
is supported by functional evidence showing MET-2 modifies chromatin-associated
histones.
supported_by:
- reference_id: file:worm/met-2/met-2-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: Nucleus... Chromosome {ECO:0000305|PubMed:22939621}'
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: MET-2 is found in both cytoplasm and nucleus, with regulated nuclear
accumulation during development. In early embryos, MET-2 is predominantly cytoplasmic
before translocating to the nucleus at gastrulation.
action: ACCEPT
reason: Cytoplasmic localization is experimentally validated. MET-2's regulated
nucleocytoplasmic distribution is an important aspect of its developmental regulation.
supported_by:
- reference_id: file:worm/met-2/met-2-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: Nucleus... Cytoplasm {ECO:0000269|PubMed:22939621}'
- reference_id: file:worm/met-2/met-2-deep-research-falcon.md
supporting_text: MET-2/LIN-65/ARLE-14 move from cytosol to nuclear hubs with
development
- term:
id: GO:0006351
label: DNA-templated transcription
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: This annotation is too general and does not accurately capture MET-2's
role. MET-2 does not directly participate in transcription; rather, it represses
transcription through chromatin modification.
action: MODIFY
reason: MET-2 is a negative regulator of transcription through heterochromatin
formation, not a transcription factor or component of the transcription machinery.
The annotation should be more specific about the regulatory role.
proposed_replacement_terms:
- id: GO:0010629
label: negative regulation of gene expression
- term:
id: GO:0007548
label: sex differentiation
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: MET-2 plays a role in meiotic sex chromosome inactivation (MSCI) in males.
Checchi & Engebrecht (PMID:21909284) showed that MET-2 mediates the transcriptional
silencing program of meiotic sex chromosome inactivation. However, this is not
a core function of MET-2.
action: KEEP_AS_NON_CORE
reason: While MET-2 does function in sex-related processes (MSCI), this represents
a context-specific application of its general heterochromatin-forming activity
rather than a core function.
supported_by:
- reference_id: PMID:21909284
supporting_text: MET-2 also mediates the transcriptional silencing program of
meiotic sex chromosome inactivation (MSCI)
- term:
id: GO:0008168
label: methyltransferase activity
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: MET-2 is indeed a methyltransferase, but this term is too general. The
specific activity is histone H3K9 methyltransferase activity (GO:0046974).
action: MODIFY
reason: While accurate, this general term should be replaced with the more specific
H3K9 methyltransferase activity annotation that better describes MET-2's enzymatic
function.
proposed_replacement_terms:
- id: GO:0046974
label: histone H3K9 methyltransferase activity
- term:
id: GO:0008270
label: zinc ion binding
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: MET-2's pre-SET domain binds zinc ions in a triangular cluster arrangement.
The UniProt entry documents multiple zinc binding sites in the pre-SET and post-SET
domains (positions 973, 975, 979, 985, 987, 1030, 1034, 1036, 1041, 1237, 1290,
1292, 1297).
action: ACCEPT
reason: Zinc binding is structurally important for SET domain-containing methyltransferases
and is well-documented for MET-2 based on domain architecture.
supported_by:
- reference_id: file:worm/met-2/met-2-uniprot.txt
supporting_text: In the pre-SET domain, Cys residues bind 3 zinc ions that are
arranged in a triangular cluster
- term:
id: GO:0016740
label: transferase activity
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: This is a very general parent term. MET-2 does have transferase activity
as it transfers methyl groups, but more specific terms are available.
action: MODIFY
reason: Too general. Should be annotated with the specific histone methyltransferase
activity terms.
proposed_replacement_terms:
- id: GO:0046974
label: histone H3K9 methyltransferase activity
- term:
id: GO:0030154
label: cell differentiation
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: MET-2 does play roles in developmental processes including vulval cell
fate specification and neuronal differentiation. However, this is a broad term
that encompasses many specific processes.
action: KEEP_AS_NON_CORE
reason: While MET-2 does function in cell differentiation contexts (vulval cells,
neurons), these are downstream consequences of its core heterochromatin-forming
function rather than direct involvement in differentiation machinery.
- term:
id: GO:0032259
label: methylation
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: MET-2 catalyzes histone methylation, specifically H3K9 mono- and dimethylation.
This general biological process term is accurate but lacks specificity.
action: ACCEPT
reason: Accurate but general. This term captures the biochemical process but more
specific annotations (histone H3K9 methyltransferase activity) better describe
the function.
- term:
id: GO:0042054
label: histone methyltransferase activity
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: MET-2 is a histone methyltransferase. The annotation is correct but the
more specific term GO:0046974 (histone H3K9 methyltransferase activity) should
be preferred.
action: ACCEPT
reason: Accurate annotation based on domain architecture. MET-2 contains SET,
pre-SET, and post-SET domains characteristic of histone methyltransferases.
supported_by:
- reference_id: file:worm/met-2/met-2-uniprot.txt
supporting_text: Histone methyltransferase which is required for the mono- and
dimethylation of 'Lys-9' of histone H3
- term:
id: GO:0046872
label: metal ion binding
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: MET-2 binds zinc ions through its pre-SET and post-SET domains. This
general term is accurate but the more specific zinc ion binding (GO:0008270)
is preferred.
action: ACCEPT
reason: Accurate but general. Zinc binding is documented and functionally relevant
for the SET domain architecture.
- term:
id: GO:0046974
label: histone H3K9 methyltransferase activity
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: MET-2 catalyzes H3K9 mono- and dimethylation. This is the core molecular
function and is well-supported by experimental evidence.
action: ACCEPT
reason: Core molecular function annotation. Redundant with IBA and IMP annotations
but correctly captures the enzymatic activity.
supported_by:
- reference_id: PMID:22939621
supporting_text: MET-2, a SETDB1 homolog, mediates mono- and dimethylation
- term:
id: GO:0051321
label: meiotic cell cycle
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: MET-2 functions in meiosis, particularly in meiotic sex chromosome inactivation
and checkpoint regulation. PMID:21909284 shows MET-2 shields the male X chromosome
from checkpoint machinery and mediates MSCI.
action: KEEP_AS_NON_CORE
reason: While MET-2 does function during meiosis, this represents a specific developmental
context for its general heterochromatin function rather than direct involvement
in cell cycle progression.
supported_by:
- reference_id: PMID:21909284
supporting_text: MET-2 shields the male X chromosome from checkpoint machinery
and mediates meiotic sex chromosome inactivation
- term:
id: GO:0140948
label: histone H3K9 monomethyltransferase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: MET-2 specifically catalyzes H3K9 monomethylation as the first step in
sequential H3K9 methylation. This is a core enzymatic activity supported by
PMID:22939621.
action: ACCEPT
reason: This specific molecular function is well-documented. MET-2 catalyzes the
first step (H3K9me0 to H3K9me1) of the H3K9 methylation pathway.
supported_by:
- reference_id: PMID:22939621
supporting_text: MET-2, a SETDB1 homolog, mediates mono- and dimethylation
- reference_id: file:worm/met-2/met-2-uniprot.txt
supporting_text: Histone methyltransferase which is required for the mono- and
dimethylation of 'Lys-9' of histone H3
- term:
id: GO:0005634
label: nucleus
evidence_type: IC
original_reference_id: PMID:17634190
review:
summary: Nuclear localization inferred by curator from the gene's function in
transcriptional repression via histone modification.
action: ACCEPT
reason: Correct annotation. Nuclear localization is experimentally validated in
multiple studies.
supported_by:
- reference_id: PMID:17634190
supporting_text: met-2 is homologous to human SETDB1, an H3K9 HMT that represses
transcription
- reference_id: file:worm/met-2/met-2-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:22939621}'
- term:
id: GO:0046974
label: histone H3K9 methyltransferase activity
evidence_type: IMP
original_reference_id: PMID:17634190
review:
summary: Andersen & Horvitz demonstrated that met-1 and met-2 mutant embryos had
reduced H3K9 trimethylation, indicating MET-2 contributes to H3K9 methylation.
While this study focused on trimethylation phenotypes, later work (PMID:22939621)
clarified that MET-2 specifically mediates mono- and dimethylation.
action: ACCEPT
reason: Core molecular function with direct experimental support. The IMP evidence
from mutant phenotypes supports H3K9 methyltransferase activity.
supported_by:
- reference_id: PMID:17634190
supporting_text: met-1 and met-2 (1) are each required for the normal trimethylation
of both H3K9 and H3K36
- term:
id: GO:0046975
label: histone H3K36 methyltransferase activity
evidence_type: IMP
original_reference_id: PMID:17634190
review:
summary: Andersen & Horvitz reported that met-2 mutants showed reduced H3K36 trimethylation.
However, this is likely an indirect effect. MET-2 is homologous to SETDB1, which
is an H3K9-specific methyltransferase. MET-1 (SET2 homolog) is the direct H3K36
methyltransferase. The observed H3K36me3 reduction in met-2 mutants may reflect
crosstalk between these marks or indirect effects on MET-1 activity.
action: REMOVE
reason: This annotation is likely incorrect based on evolutionary conservation
and biochemical specificity. SETDB1-family proteins are H3K9-specific methyltransferases.
The observed H3K36me3 phenotype in met-2 mutants is more likely an indirect
consequence of H3K9me loss affecting H3K36 methylation machinery, not direct
catalytic activity on H3K36. UniProt catalytic activity annotations (EC 2.1.1.367)
specify H3K9 as the substrate.
supported_by:
- reference_id: PMID:17634190
supporting_text: met-1 and met-2 (1) are each required for the normal trimethylation
of both H3K9 and H3K36
- term:
id: GO:0010629
label: negative regulation of gene expression
evidence_type: IMP
original_reference_id: PMID:24348272
review:
summary: Uchida et al. showed that met-2 mutants derepress unc-4 expression in
vulval VC neurons. "Endogenous unc-4 transcripts accumulate in all six VC neurons
in pqe-1, cec-3, and met-2 mutants" - demonstrating MET-2's role in silencing
subtype-specific gene expression.
action: ACCEPT
reason: Core biological process with direct experimental evidence. Loss of met-2
leads to ectopic gene expression, demonstrating negative regulation of gene
expression.
supported_by:
- reference_id: PMID:24348272
supporting_text: Endogenous unc-4 transcripts accumulate in all six VC neurons
in pqe-1, cec-3, and met-2 mutants
- reference_id: PMID:24348272
supporting_text: MET-2 is the C. elegans homolog of human SETDB1
- term:
id: GO:0040029
label: epigenetic regulation of gene expression
evidence_type: IMP
original_reference_id: PMID:24979765
review:
summary: Kerr et al. demonstrated that MET-2 functions in transgenerational epigenetic
reprogramming with SPR-5. SPR-5 and MET-2 function cooperatively to reestablish
an epigenetic ground state during passage through the germ line. spr-5;met-2
double mutants show transgenerational sterility and heritable epigenetic defects.
action: ACCEPT
reason: Core biological process demonstrating MET-2's role in epigenetic inheritance
and germline reprogramming. This is a key function supported by strong experimental
evidence.
supported_by:
- reference_id: PMID:24979765
supporting_text: SPR-5 and MET-2 function cooperatively to reestablish an epigenetic
ground state during passage through the germ line
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IDA
original_reference_id: PMID:22939621
review:
summary: Towbin et al. demonstrated cytoplasmic localization of MET-2, particularly
in early embryos before nuclear accumulation. The regulated nucleocytoplasmic
distribution is an important aspect of developmental timing of heterochromatin
formation.
action: ACCEPT
reason: Direct experimental evidence (IDA) for cytoplasmic localization. MET-2's
regulated nuclear import is key to timing heterochromatin establishment.
supported_by:
- reference_id: PMID:22939621
supporting_text: 'The two HMTs target H3K9 in a consecutive fashion: MET-2,
a SETDB1 homolog, mediates mono- and dimethylation'
- reference_id: file:worm/met-2/met-2-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: Nucleus... Cytoplasm {ECO:0000269|PubMed:22939621}'
- reference_id: file:worm/met-2/met-2-deep-research-falcon.md
supporting_text: MET-2/LIN-65/ARLE-14 move from cytosol to nuclear hubs with
development
- term:
id: GO:0045835
label: negative regulation of meiotic nuclear division
evidence_type: IMP
original_reference_id: PMID:21909284
review:
summary: Checchi & Engebrecht showed that MET-2 shields the male X chromosome
from checkpoint machinery. Loss of met-2 leads to increased apoptosis through
activation of the recombination checkpoint in X0 germ lines. However, MET-2
does not directly regulate meiotic division; rather, it prevents checkpoint-induced
cell death.
action: KEEP_AS_NON_CORE
reason: This represents a specific context-dependent phenotype rather than a direct
role in regulating meiotic nuclear division. MET-2's function here is to silence
the X chromosome to prevent inappropriate checkpoint activation, not to directly
regulate meiosis.
supported_by:
- reference_id: PMID:21909284
supporting_text: Absence of met-2 in X0 germ lines results in increased apoptosis
by activating the recombination checkpoint
- reference_id: PMID:21909284
supporting_text: Absence of MET-2 triggers the recombination checkpoint in worms
with a single X
- term:
id: GO:0072325
label: vulval cell fate commitment
evidence_type: IMP
original_reference_id: PMID:21437264
review:
summary: Koester-Eiserfunke & Fischle demonstrated that MET-2 functions in vulval
cell fate determination through H3K9 methylation. LIN-61 acts with HPL-2 and
MET-2 in this pathway. Double mutants between lin-61 and met-2 show enhanced
vulval defects.
action: KEEP_AS_NON_CORE
reason: Vulval development is a well-studied context for MET-2 function, but this
is a tissue-specific manifestation of the general gene silencing function rather
than a core function of the protein.
supported_by:
- reference_id: PMID:21437264
supporting_text: establish interplay of the H3K9me2/3 binding proteins, LIN-61
and HPL-2, as well as the H3K9MT MET-2 in distinct developmental pathways
- reference_id: PMID:17634190
supporting_text: identified met-1 and met-2 as negative regulators of vulval
cell-fate specification
- term:
id: GO:0000122
label: negative regulation of transcription by RNA polymerase II
evidence_type: IGI
original_reference_id: PMID:17634190
review:
summary: Andersen & Horvitz showed that MET-2 represses lin-3 EGF transcription.
Genetic interactions demonstrate that met-1 and met-2 act redundantly with HP1
homologs to repress transcription.
action: ACCEPT
reason: Direct evidence for transcriptional repression function. This is more
specific than the general "negative regulation of gene expression" and captures
the mechanism of action.
supported_by:
- reference_id: PMID:17634190
supporting_text: repress transcription of the EGF gene lin-3, which encodes
the signal that induces vulval development
- term:
id: GO:0040027
label: negative regulation of vulval development
evidence_type: IGI
original_reference_id: PMID:17634190
review:
summary: MET-2 negatively regulates vulval development by repressing lin-3 EGF
expression. Genetic interactions with HP1 homologs and NuRD complex components
support this role.
action: KEEP_AS_NON_CORE
reason: While experimentally validated with strong genetic evidence, vulval development
regulation is a tissue-specific phenotype resulting from MET-2's general function
in transcriptional repression rather than a core function.
supported_by:
- reference_id: PMID:17634190
supporting_text: identified met-1 and met-2 as negative regulators of vulval
cell-fate specification
- reference_id: PMID:17634190
supporting_text: repress transcription of the EGF gene lin-3, which encodes
the signal that induces vulval development
- term:
id: GO:0140942
label: histone H3K9 dimethyltransferase activity
evidence_type: IMP
original_reference_id: PMID:22939621
review:
summary: MET-2 catalyzes the conversion of H3K9me1 to H3K9me2. Towbin et al. demonstrated
that "MET-2, a SETDB1 homolog, mediates mono- and dimethylation" of H3K9.
action: NEW
reason: This specific enzymatic activity is a core molecular function of MET-2
and should be annotated. H3K9 dimethyltransferase activity (GO:0140942) specifically
captures the me1-to-me2 conversion that MET-2 catalyzes.
supported_by:
- reference_id: PMID:22939621
supporting_text: MET-2, a SETDB1 homolog, mediates mono- and dimethylation
- reference_id: file:worm/met-2/met-2-deep-research-falcon.md
supporting_text: approximately 10-fold H3K9me2 increase between 20-50 and 51-100
cell stages
- term:
id: GO:0140719
label: constitutive heterochromatin formation
evidence_type: IMP
original_reference_id: PMID:22939621
review:
summary: MET-2 is essential for constitutive heterochromatin formation through
H3K9me2 deposition. This mark is characteristic of constitutive heterochromatin
in metazoa.
action: NEW
reason: Constitutive heterochromatin formation is more specific than "heterochromatin
organization" and better captures MET-2's role in establishing stable, refractory
chromatin domains at repeats and the nuclear periphery.
supported_by:
- reference_id: PMID:22939621
supporting_text: elimination of two HMTs, MET-2 and SET-25, mimics the loss
of SAM synthetase, abrogating the perinuclear attachment of heterochromatic
transgenes
- reference_id: file:worm/met-2/met-2-deep-research-falcon.md
supporting_text: MET-2/H3K9me2 is essential for perinuclear anchoring of autosomal
arms
- term:
id: GO:0010526
label: transposable element silencing
evidence_type: IMP
original_reference_id: PMID:27668659
review:
summary: MET-2 and SET-25 together protect repeat-rich genomic regions including
transposable elements by suppressing transcription-induced replication stress
through H3K9 methylation.
action: NEW
reason: Transposon silencing is a key function of H3K9 methyltransferases and
represents a core biological process for MET-2. The UniProt function annotation
specifically mentions this role.
supported_by:
- reference_id: PMID:27668659
supporting_text: H3K9me2 or H3K9me3 stabilizes and protects repeat-rich genomes
by suppressing transcription-induced replication stress
- reference_id: file:worm/met-2/met-2-deep-research-falcon.md
supporting_text: loss destabilizes nuclear MET-2, lowers H3K9me2, disperses
foci, and derepresses repeats
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO
terms
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000043
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
vocabulary mapping
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning models
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:17634190
title: Two C. elegans histone methyltransferases repress lin-3 EGF transcription
to inhibit vulval development.
findings:
- statement: MET-2 is homologous to human SETDB1, an H3K9 HMT that represses transcription
supporting_text: met-2 is homologous to human SETDB1, an H3K9 HMT that represses
transcription
- statement: met-1 and met-2 are each required for normal trimethylation of both
H3K9 and H3K36
supporting_text: met-1 and met-2 (1) are each required for the normal trimethylation
of both H3K9 and H3K36
- statement: met-1 and met-2 act redundantly with C. elegans HP1 homologs
supporting_text: act redundantly with each other as well as with the C. elegans
HP1 homologs
- statement: MET-2 represses transcription of lin-3 EGF gene
supporting_text: repress transcription of the EGF gene lin-3, which encodes the
signal that induces vulval development
- id: PMID:20107519
title: Differential localization and independent acquisition of the H3K9me2 and
H3K9me3 chromatin modifications in the Caenorhabditis elegans adult germ line.
findings:
- statement: MET-2 is required for H3K9 mono- and dimethylation
supporting_text: MET-2 is required for adult germline H3K9me2 but not H3K9me3
- id: PMID:21437264
title: H3K9me2/3 binding of the MBT domain protein LIN-61 is essential for Caenorhabditis
elegans vulva development.
findings:
- statement: LIN-61, HPL-2, and MET-2 function together in vulva development
supporting_text: establish interplay of the H3K9me2/3 binding proteins, LIN-61
and HPL-2, as well as the H3K9MT MET-2 in distinct developmental pathways
- statement: H3K9me2/3 interaction is central to vulval cell fate determination
supporting_text: Interestingly, lin-61 genetically interacts with two other synMuvB
genes, hpl-2, an HP1 homologous H3K9me2/3 binding factor, and met-2, a SETDB1
homologous H3K9 methyl transferase (H3K9MT), in determining C
- id: PMID:21909284
title: Caenorhabditis elegans histone methyltransferase MET-2 shields the male X
chromosome from checkpoint machinery and mediates meiotic sex chromosome inactivation.
findings:
- statement: MET-2 mediates meiotic sex chromosome inactivation (MSCI)
supporting_text: that MET-2 also mediates the transcriptional silencing program
of meiotic sex chromosome inactivation
- statement: MET-2 blocks checkpoint signaling on the partnerless male X chromosome
supporting_text: Absence of MET-2 triggers the recombination checkpoint in worms
with a single X
- statement: Loss of met-2 causes increased apoptosis through checkpoint activation
supporting_text: Absence of met-2 in X0 germ lines results in increased apoptosis
by activating the recombination checkpoint
- id: PMID:22939621
title: Step-wise methylation of histone H3K9 positions heterochromatin at the nuclear
periphery.
findings:
- statement: MET-2 mediates H3K9 mono- and dimethylation
supporting_text: 'The two HMTs target H3K9 in a consecutive fashion: MET-2, a
SETDB1 homolog, mediates mono- and dimethylation'
- statement: SET-25 mediates H3K9 trimethylation
supporting_text: SET-25, a previously uncharacterized HMT, deposits H3K9me3
- statement: MET-2 and SET-25 together position heterochromatin at nuclear periphery
supporting_text: elimination of two HMTs, MET-2 and SET-25, mimics the loss of
SAM synthetase, abrogating the perinuclear attachment of heterochromatic transgenes
- statement: MET-2 is a SETDB1 homolog
supporting_text: MET-2, a SETDB1 homolog, mediates mono- and dimethylation
- id: PMID:24348272
title: Histone methylation restrains the expression of subtype-specific genes during
terminal neuronal differentiation in Caenorhabditis elegans.
findings:
- statement: MET-2 silences subtype-specific genes during neuronal differentiation
supporting_text: MET-2 is the C. elegans homolog of human SETDB1 and Drosophila
Eggless
- statement: met-2 mutants show ectopic unc-4 expression in VC neurons
supporting_text: Endogenous unc-4 transcripts accumulate in all six VC neurons
in pqe-1, cec-3, and met-2 mutants
- id: PMID:24685137
title: A histone methylation network regulates transgenerational epigenetic memory
in C. elegans.
findings:
- statement: MET-2 required for small-RNA-induced H3K9 methylation
supporting_text: identified multiple chromatin-modifying factors, including H3K4me1/me2
and H3K9me3 methyltransferases
- id: PMID:24979765
title: SPR-5 and MET-2 function cooperatively to reestablish an epigenetic ground
state during passage through the germ line.
findings:
- statement: MET-2 functions with SPR-5 in germline epigenetic reprogramming
supporting_text: SPR-5 and MET-2 function cooperatively to reestablish an epigenetic
ground state
- statement: spr-5;met-2 double mutants have synergistic sterility
supporting_text: spr-5;met-2 double mutants have a synergistic effect on sterility,
H3K4me2, and spermatogenesis expression
- statement: MET-2 contributes to transgenerational epigenetic inheritance
supporting_text: mutants in the H3K9me2 methyltransferase, met-2, result in transgenerational
epigenetic effects
- id: PMID:26365259
title: The Nrde pathway mediates small-RNA-directed histone H3 lysine 27 trimethylation
in Caenorhabditis elegans.
findings:
- statement: MET-2 required for small-RNA-induced H3K9 methylation
supporting_text: Whereas set-25 and met-2 are required for K9 methylation, mes-2
is required for K27 methylation
- id: PMID:27668659
title: Histone H3K9 methylation is dispensable for Caenorhabditis elegans development
but suppresses RNA:DNA hybrid-associated repeat instability.
findings:
- statement: MET-2 and SET-25 together protect repeat-rich genomic regions
supporting_text: In met-2 set-25 double mutants, which lack all H3K9 methylation
(H3K9me), embryos differentiate normally
- statement: H3K9 methylation suppresses transcription-induced replication stress
supporting_text: H3K9me2 or H3K9me3 stabilizes and protects repeat-rich genomes
by suppressing transcription-induced replication stress
- id: file:worm/met-2/met-2-deep-research-falcon.md
title: Deep research summary for MET-2
findings:
- statement: MET-2 nuclear accumulation times heterochromatin onset
- statement: LIN-65 rate-limits MET-2 nuclear entry
- statement: ARLE-14 stabilizes MET-2 chromatin association
- statement: Approximately 10-fold H3K9me2 increase at gastrulation
- statement: MET-2 forms nuclear foci with LIN-65
- statement: met-2 mutants abolish perinuclear anchoring of autosomal arms
- statement: H3K9me2 (not me3) is required for lamina tethering
- statement: Catalytically inactive MET-2 still forms foci and maintains some gene
silencing
- statement: Noncatalytic function involves constraining histone acetylation
core_functions:
- molecular_function:
id: GO:0046974
label: histone H3K9 methyltransferase activity
description: MET-2 is the principal H3K9 mono- and dimethyltransferase in C. elegans,
homologous to mammalian SETDB1. It catalyzes sequential addition of methyl groups
to H3K9 using SAM as methyl donor. This is supported by genetic evidence (met-2
mutants lose H3K9me2) and biochemical conservation with SETDB1 family proteins
(PMID:22939621, PMID:20107519).
- molecular_function:
id: GO:0140948
label: histone H3K9 monomethyltransferase activity
description: MET-2 catalyzes the first step of H3K9 methylation (me0 to me1). This
activity primes chromatin for subsequent dimethylation by MET-2 and trimethylation
by SET-25 (PMID:22939621).
- molecular_function:
id: GO:0140942
label: histone H3K9 dimethyltransferase activity
description: MET-2 catalyzes H3K9me1 to H3K9me2 conversion. H3K9me2 is the primary
mark responsible for perinuclear heterochromatin anchoring (Delaney et al. 2019).
directly_involved_in:
- id: GO:0070828
label: heterochromatin organization
- id: GO:0010629
label: negative regulation of gene expression
locations:
- id: GO:0005634
label: nucleus
proposed_new_terms: []
suggested_questions:
- question: Is MET-2 H3K9me1 activity truly sequential (me0->me1 then me1->me2) or
can it add two methyl groups processively?
- question: What targets MET-2 to specific genomic loci - is it small RNA-dependent
targeting via NRDE-3?
- question: Does MET-2 have any non-histone substrates?
- question: What is the molecular basis for the noncatalytic silencing function of
MET-2?
suggested_experiments:
- description: In vitro methyltransferase assay with recombinant MET-2 to confirm
H3K9me1 and H3K9me2 product formation
- description: ChIP-seq for MET-2 compared to H3K9me2 to identify direct genomic targets
- description: Structural studies of MET-2-LIN-65-ARLE-14 complex
- description: Identify MET-2 interacting proteins by IP-MS in embryos at different
developmental stages
tags:
- caeel-upr-stress